Podium Presentations-Medicinal
Chemistry
S83
I Eur. J. Pharm. Sci. 4 Suppl. (1996) S83-S84
clonidine
The well known drugs such "
ox
nr~~~~ldiru
that
structure have bean d-trated to act aa a,
[email protected], recently centrally nadiatad anti-rtenaiva sc~lon of theas compuda ia belived to be mediated by is difficult to dirrociate I, imidaaolina rrcaprorr. It
have
Recently, we reported our studies with compounds,containing aMwncene OTacridine covalently linked, at position-Q,through an amide bond to spermine affording conjugateswith biinctional modes of DNA binding (Adlam et al. 1994; Rodger et al. 1994; Carrington et al. 1996). These compoundswere cytotoxicagainst 616 murine melanoma cells. We now report novel acridine conjugates which were synthesised by N-alkylation at position-9 by spermine or by spermine linked to one or two molecules of 5-aminovaleric acid. These 5aminovaleric acid units were incorporatedin the conjugates in order to introduce a region offlexibilitybetween the acridine and the spermine, allowing the two binding regions to optimise their interactions. In order to minimize side reactions, spermine was protected on three amine groups with benzykntycarbonylgroups (Canington et al. 1996) leaving one free terminal amine. Spermine acylations were carried out uiing DCC as the coupling (dehydrating)reagent and HOBt (cat.). N-Alkylations onto acridine were achieved by the displacement of phenoxide from Sphenoxyacridine in molten phenol (16 h). The polyamine conjugate was finally deprotected by hydrogenolysis. These synthetic 9-aminoacridine conjugateswere assayed on B16 murina melanoma cells in the tetrazolium microtitreplate (MIT) assay as described by Mosmann (1963). The spennin&-acridine conjugate showed an EC50 of 2.3xltVM, an order of magnitude better than any of our amide conju9etes previouslyreported (Carrirgton et al. 1996). The conjugate with one spacer had a similar EC50 of 3.2~10% The Mmpound with two spacers had an EC50 of 5.6x10-%4, showing it to have significantlyless activity than either of the other two conjugates.
imidaaolti
an
receptors
iinidaaolina molecular
level
from
Uaucturo
imidarolina
a,-adrenoraceptorr
axbibit
the availability
Therefore. vith
they
am
an0
Of
dagrer
the
at
rimilarity.
Of ns* MmlypertrMiw agentn rtimulaea further reaauch rubtile ?? trucWre of theaa two rbould
towarda elucidating tha receptor clurea. In Chia cawnication tha aynthoaia, crystal and molecular structure 01 veil M biological activkirr of the itidaroline derivativea
?,
3 and 4 will
be diawred
in
detail.
Adlam, G. et al. (1994) Bioorg. Med. Chem. Lett. 4: 24352440 Carrington, S. et al. (1996) Pharm. Sci. 2: 25-27 Mosmann, T. (1963) J. Immunol.Methods 65: 55-63 Rodger, A et al. (1994) Biopolymers34: 1563-l 594
Bolaamphiphilic lipids are the constituents of the membranes of archaebacteria which have surprisingly stable membranes. In continuation of our previous works on the synthesis and biophysical/biochcmical studies of glycolipids [ 1,2]. we are interested to use bipolar glycolipid systems with two sugar moieties at both the ends of a long hydrophobic chain with or without ethoxy unit as spacers. The required starting material a, o-dials 2 are prepared tbrougb the condensation of the corresponding lower homologues in four steps. Monoetberification with tetra- or penmethylene glycol can be achieved starting from a,o-dibromides, obtained by bromination of the corresponding a. odials. .sup HO(CH2)xOH
-
Heam”
HO(CH2)nON -
HO(CH&,$JH
2
Br(CH,),,Br %W”p,O!&
HO(CH&w’JH
HO(CH2CH20),,,/
W2h
pA,
n =
19
where
Se,,
oxygen
is
IIT_ 2)“MW
f!-Gly-O(CH2CH2O~m/(cH2)n
WB4101
1 ..0. m-l2.X m-4c.I. ..llrr,l
oxygen
difference
of energy and
to
the
on
ring
a derivative,
1Ai?,,,,,,
13 9
= 0838
1
s = 0439
F = 416
superdelocalisability
on
the
side-chain,
is
the
carbon
of the highest
atom attached
and Dw
2,
Sn,
benzodioxan nucleophilic
1AEHOMO 1 is the
occupied
of
between betweenthe chain
molecular
is the distance
10 the methoxy-substituted
modulus
orbital
ring and the farthest non-
atom para to that oxygen
equation
indicates
0 018 SnU-
Q2
electrophilic
adjacent
superdelocalisability
hydrogen
= 0 274 SQ,-
r-’ = 0 922
BGly-O(CH2CH20),,,\
A.lbgd.KAu~uabF. Wilhdm.S.KaIaaajamdP.Nuhn.Archiv Phamz. 326(1993)&(8. P. Nuhn.T. PM. 0. Bedas. F. Wilhelm S.K.Chsaaja.ibid,327. (1994) 429. S.K:Chu~. F. Wilhelm. P. Nuhh Eur. 1. Ph Sci. 2 (L994) 95. F. Wilhelm. S.K.Chatterjee.B. Ratmy, P. Nuhn. R. Bmske and I. Or&vein, Licbip Am.. (19%) 1673
We
H3CYo have carried out a quantitative structure-activiry relationship (QSAR) study of 19 derivatives, with the aims of improving potency and elucidating the drug-receptor interaction The best correlation obtained was’
The I. 2. 3. 4.
structureshownbelow.
has the
HWCHzCHzO),\
As was done in our previous works 13.41 the reaction of pentaacetyl monosaccharide (GlycAc,; glyc- = Glc, Man. Gal) 1 with a.o-dials 2 in presence of triflale and molsieves lead to stereospecific j%aoomer 3 (trclnsglycosidation) in good yields.
ClycAcS + 2 v
wB4101 is a potent al-blockerwhich
the
adrenoceptor
permits key
the prediction
interaction
points
of compounds of
the
of high potency,
compounds
with
the
and a,
’